Phase I study of amrubicin (AMR) for patients (pts) with previously treated small cell lung cancer (SCLC)

被引：0
|
作者：
Katakami, N.
Hata, A.
Yoshioka, H.
Higashi, Y.
Nishimura, T.
Sakaguchi, S.
Hayashi, M.
Tomii, K.
Naya, R.
Ishihara, K.
机构：
[1] Kobe City Gen Hosp, Kobe, Hyogo, Japan
[2] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18209
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC).
    Kato, T.
    Nokihara, H.
    Ohe, Y.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Kubota, K.
    Nishiwaki, Y.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [2] Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)
    Sugawara, S.
    Inoue, A.
    Yamazaki, K.
    Saijo, Y.
    Gomi, K.
    Ishimoto, O.
    Hommura, F.
    Maemondo, M.
    Suzuki, T.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A phase I study of amrubicin (AMR) and irinotecan (CPT-11) in relapsed small cell lung cancer(SCLC)
    Kawahara, M.
    Kubo, A.
    Komuta, K.
    Fukushima, M.
    Daimon, T.
    Furuse, K.
    Mio, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase II study of amrubicin (AMR) in patients (pts) with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: WJTOG0401
    Hayashi, H.
    Kaneda, H.
    Okamoto, I.
    Miyazaki, M.
    Kudoh, S.
    Sawa, T.
    Takeda, K.
    Negoro, S.
    Iwamoto, Y.
    Nakagawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Survival improvement in patients (pts) with small cell lung cancer (SCLC): A historical comparison before and after amrubicin (AMR) approval in Japan
    Niho, S.
    Kubota, K.
    Yoh, K.
    Goto, K.
    Ohmatsu, H.
    Ohe, Y.
    Nishiwaki, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer
    Ikeda, J
    Maruyama, R
    Okamoto, T
    Shoji, F
    Wataya, H
    Ichinose, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 12 - 16
  • [7] Final result of phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for elderly patients with small cell lung cancer (SCLC)
    Ishimoto, O.
    Inoue, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study
    Paz-Ares, L.
    Ahn, M-J.
    Felip, E.
    Handzhiev, S.
    Korantzis, I.
    Izumi, H.
    Ohashi, K.
    Majem Tarruella, M.
    Wolf, J.
    Reck, M.
    Hummel, H-D.
    Blackhall, F.
    Dingemans, A-M. C.
    Owonikoko, T. K.
    Ramalingam, S. S.
    Sands, J.
    Jiang, T.
    Mukherjee, S.
    Anderson, E.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1664 - S1665
  • [9] Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study
    Paz-Ares, L.
    Ahn, M-J.
    Felip, E.
    Handzhiev, S.
    Korantzis, I.
    Izumi, H.
    Ohashi, K.
    Majem, M.
    Wolf, J.
    Reck, M.
    Hummel, H-D.
    Blackhall, F.
    Dingemans, A-M. C.
    Owonikoko, T. K.
    Ramalingam, S. S.
    Sands, J.
    Jiang, T.
    Mukherjee, S.
    Anderson, E.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1333 - S1334
  • [10] PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR ELDERLY PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). (NORTH JAPAN LUNG CANCER GROUP 0405)
    Nakamura, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    Inoue, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 118
12345